Fact Based List:

Novartis AG's top 10 drugs based on revenue in 2017

Submitted by Anonymous on Fri, 02/23/2018 - 13:02


  1. Gilenya $3.185 billion
  2. Cosentyx $2.071 billion
  3. Gleevec/glivec $1.943 billion
  4. Lucentis $1.888 billion
  5. Tasigna $1.841 billion
  6. Sandostatin $1.612 billion
  7. Afinitor/Votubia $1.525 billion
  8. Galvus $1.233 billion
  9. Exjade $1.059 billion
  10. Exforge $0.960 billion


Source: Statista
Source URL: https://www.statista.com/statistics/278114/novartis-top-drug...


Printer-friendly versionPrinter-friendly versionSend to friendSend to friendmore...  

List Ratings:   
0
No votes yet
Your rating: None

Lists You Might Also Be Interested In



    Login or register to post comments